Key result
Rauwolfia serpentina and reserpine lack reported blood pressure outcomes for essential hypertension in the abstract.
Why the study?
Does Rauwolfia serpentina and reserpine reduce blood pressure in ambulatory patients with essential hypertension?
Does Rauwolfia serpentina and reserpine reduce blood pressure in ambulatory patients with essential hypertension?
Answers are grounded in this paper and cite their sources.
Absence of reported effect sizes precludes practice change; leaves open Rauwolfia efficacy in essential hypertension.
A 2-year double-blind study of 18 ambulatory patients treated with Rauwolfia serpentina and reserpine is presented, with a statistical evaluation by the method of analysis of variance.
No takes yet. Share an insight, caveat, or question.
SHELDON et al. (1957) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: